公司展望說明會

海外公司回響熱烈 歐美菲澳等國競相參與

撰文新聞中心
日期2021-05-31
今年度公司展望會海外報名熱絡,歐美菲澳等國競相參與。


本次參與的公司包含吹灌封技術(Blow-Fill-Seal)的全球領先者Rommelag AG、擁有豐富臨床經驗的Pivot、專業生物分析實驗室Agilex Biolabs等,他們將以其強韌的研發量能,帶給潛力夥伴國際視野與無限商機!
 

開啟商機,立即註冊!

 

EVERSANA

EVERSANA™ is the leading provider of global commercial services to the life sciences industry. Our integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. We serve more than 500 organizations, including innovative start-ups and established pharmaceutical companies to advance life science solutions for a healthier world.

Rommelag ENGINEERING

Rommelag is the inventor and global leader in Blow-Fill-Seal technology (BFS) which has been used to package liquid and semi-solid pharmaceutical products since the 1960’s. Our advanced aseptic process uses plastic polymer material to form, fill and hermetically seal a container in a highly integrated process. With the packaging of sterile liquids, gels, pastes and vaccines we serve the pharmaceutical, healthcare, cosmetic and chemical industries. Together with our customers, we develop innovative packaging solutions tailored precisely to their specific packaging task. We have customers in over 80 countries and more than 2,000 bottelpack systems in active use around the world. 


 

Exopharm Ltd

Exopharm is a clincial-stage Australian biotechnology company using exosomes (extracellular vesicles (EVs)) from cells to generate a new class of transformative medicines. The company’s proprietary EV engineering technologies enable improved loading of nucleic acid medicines into EVs, and allow EVs to be directed towards selected cell types. Together with its LEAP technology, which allows large-scale and economical isolation of exosomes, Exopharm is using combinations of its engneering technologies to develop a pipeline of EEV products for a range of clinical applications, including neurological diseases, infectious diseases, cancer and fibrosis.
 

Alira Health

Our global team delivers revolutionary solutions and unparalleled support to help clients set new standards of care. We guide growth and innovation across product and business lifecycles through a fully integrated suite of services that span the healthcare and life sciences ecosystem

AGC Bio

OUR MISSION: To work side by side with our customers in order to improve patients’ lives by bringing new biopharmaceuticals to market.
OUR VISION: To be the first provider that customers call when they are looking for a Contract Development Manufacturing Organization.
OUR VALUES: ·Innovation & Operational Excellence ·Diversity ·Protect the Environment ·Integrity

HTW Berlin, Zentrum für berufsbegleitendes und weiterbildendes Studium

HTW Berlin is the largest University of Applied Sciences in Berlin, Germany. The international MBA&E Life Science Management Programme offers ambitious professionals a stepping stone leveraging their career as a Life Science Manager.

 

Berlin Partner for Business and Technology

A unique public-private partnership, Berlin Partner for Business and Technology collaborates with the Berlin State Senate and over 230 companies dedicated to promoting their city.

St Vincents Research Valet

St Vincent’s Hospital Melbourne is part of the St Vincent’s Health Australia, a $2 billion not-for-profit health and aged care provider. We’re the second largest healthcare provider with more than 30 facilities along the eastern seaboard. SVHM is one of five tertiary teaching hospitals in Victoria. Our clinical care is supported by an inspiring and very active translational research program:

 

Agilex Biolabs

Agilex Biolabs, as Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials specialises in both LC-MS/MS and immunoassay/immunobiology services. We operate a fully quality-assured, FDA-inspected laboratory in Australia (ISO/IEC17025 and OECD GLP), offering bioanalysis for small molecules and biologics for PK, PD, immunogenicity, and biomarkers as well as an immunobiology service for evaluation of immunological endpoints by flow cytometry and cell-based assays. Agilex Biolabs would like to engage biotech and pharma companies interested in utilising Australia as their early phase clinical trial location to access regulatory speed, R&D Tax cash-back incentives and premium quality service. 

PiVOT

PiVOT is a leading Contract Research Organization (CRO) in the Philippines. With over 100 years of aggregate employee experience in clinical research - from multinational companies like Pfizer, Novartis, Boehringer-Ingelheim, GlenEagles, PPD, and IQVIA (formerly Quintiles) - we obtained our license to operate from the Philippine Food and Drug Administration in 2018. 

We are 100% owned by First Philippine Holdings Corp., a publicly-listed, Lopez-owned company, with assets of US$9B and attributable recurring net income of US$200M in power generation, real estate, construction, manufacturing, education, and healthcare.